Latest news with #Biotalys
Business Upturn
4 days ago
- Business
- Business Upturn
Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
By GlobeNewswire Published on June 11, 2025, 10:00 IST Ghent, BELGIUM, June 11, 2025 (GLOBE NEWSWIRE) — Press release Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, is pleased to announce progress in the regulatory approval procedures in both the United States and Europe of its first protein-based biocontrol product, EVOCA™*. In the US, Biotalys received a communication from the Environmental Protection Agency (EPA) that the company has provided responses to all the agency's requests for additional information. The EPA currently projects it will complete the scientific review of the EVOCA dossier later this summer and make a regulatory decision by September 30th, 2025. In Europe, Biotalys is pleased to confirm that both the Dutch Board for Authorisation of Plant Protection Products (CTGB) and the Dutch Institute for Health and Environment (RIVM) have now provided positive evaluations of EVOCA's regulatory dossier, paving the way for the peer review phase at the European level. In their review, both Dutch authorities have classified EVOCA's active ingredient as low risk based on the current data. This classification is important as it recognizes the active ingredient's safety profile and aligns with Biotalys' commitment to delivering sustainable, effective solutions for crop protection. No critical areas of concern were identified and therefore the Netherlands, as rapporteur Member State, proposes that the active ingredient of EVOCA can be approved in Europe, subject to the provision of certain additional data during the peer review phase. Biotalys' current assessment is that a regulatory decision in the European Union can be expected in the second half of 2026. Kevin Helash, Chief Executive Officer of Biotalys, said: 'We are pleased with the regulatory progress in both the US and EU, and look forward to a favorable outcome. An approval decision would be a major milestone for our company and a validation for our unique AGROBODY™ technology platform. This platform has the potential to develop many more protein-based biocontrol solutions for growers to fight key pests and diseases in agriculture. I am very grateful for the thorough review and guidance by the regulatory agencies, and for the hard work by our team to generate and provide the required scientific data on our innovative product.' The first biocontrol developed on Biotalys' AGROBODY™ technology platform, EVOCA helps safely control fungal diseases Botrytis (grey mold) and powdery mildew for fruit and vegetable growers looking to add effective, biodegradable solutions to their integrated pest management (IPM) initiatives to reduce chemical applications. * EVOCA™: Pending Registration. This product is not currently registered for sale or use in the European Union, the United States or elsewhere and is not being offered for sale. About Biotalys Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on For further information, please contact: Toon Musschoot, Head of IR & CommunicationT: +32 (0)9 274 54 00 E: [email protected] Important Notice Biotalys, its business, prospects and financial position remain exposed and subject to risks and uncertainties. A description of and reference to these risks and uncertainties can be found in the annual report on the consolidated annual accounts published on the company's website. This announcement contains statements which are 'forward-looking statements' or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. Biotalys' actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
4 days ago
- Business
- Yahoo
Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe Ghent, BELGIUM, June 11, 2025 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, is pleased to announce progress in the regulatory approval procedures in both the United States and Europe of its first protein-based biocontrol product, EVOCA™*. In the US, Biotalys received a communication from the Environmental Protection Agency (EPA) that the company has provided responses to all the agency's requests for additional information. The EPA currently projects it will complete the scientific review of the EVOCA dossier later this summer and make a regulatory decision by September 30th, 2025. In Europe, Biotalys is pleased to confirm that both the Dutch Board for Authorisation of Plant Protection Products (CTGB) and the Dutch Institute for Health and Environment (RIVM) have now provided positive evaluations of EVOCA's regulatory dossier, paving the way for the peer review phase at the European level. In their review, both Dutch authorities have classified EVOCA's active ingredient as low risk based on the current data. This classification is important as it recognizes the active ingredient's safety profile and aligns with Biotalys' commitment to delivering sustainable, effective solutions for crop protection. No critical areas of concern were identified and therefore the Netherlands, as rapporteur Member State, proposes that the active ingredient of EVOCA can be approved in Europe, subject to the provision of certain additional data during the peer review phase. Biotalys' current assessment is that a regulatory decision in the European Union can be expected in the second half of 2026. Kevin Helash, Chief Executive Officer of Biotalys, said: 'We are pleased with the regulatory progress in both the US and EU, and look forward to a favorable outcome. An approval decision would be a major milestone for our company and a validation for our unique AGROBODY™ technology platform. This platform has the potential to develop many more protein-based biocontrol solutions for growers to fight key pests and diseases in agriculture. I am very grateful for the thorough review and guidance by the regulatory agencies, and for the hard work by our team to generate and provide the required scientific data on our innovative product.' The first biocontrol developed on Biotalys' AGROBODY™ technology platform, EVOCA helps safely control fungal diseases Botrytis (grey mold) and powdery mildew for fruit and vegetable growers looking to add effective, biodegradable solutions to their integrated pest management (IPM) initiatives to reduce chemical applications.* EVOCA™: Pending Registration. This product is not currently registered for sale or use in the European Union, the United States or elsewhere and is not being offered for sale. About Biotalys Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on For further information, please contact: Toon Musschoot, Head of IR & CommunicationT: +32 (0)9 274 54 00E: IR@ Important Notice Biotalys, its business, prospects and financial position remain exposed and subject to risks and uncertainties. A description of and reference to these risks and uncertainties can be found in the annual report on the consolidated annual accounts published on the company's website. This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. Biotalys' actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by in retrieving data Sign in to access your portfolio Error in retrieving data
Yahoo
26-05-2025
- Business
- Yahoo
Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer
Seasoned Financial Executive Will Lead Finance Operations as Biotalys Pushes Product Pipeline Toward Commercialization Ghent, May 26, 2025 (GLOBE NEWSWIRE) -- Press release Ghent, BELGIUM – 26 May 2025, 07:00 CEST – Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced the appointment of Luc Van fraeyenhoven as Chief Financial Officer (CFO). He succeeds Douglas Minder, who will pursue other career opportunities. Mr. Van fraeyenhoven will transition into the role over the next few months. With more than three decades in financial roles, Mr. Van fraeyenhoven brings significant experience as a CFO in the biotechnology and medtech industries, with a strong background leading finance operations and strategy in addition to partnering closely with the boards of various companies throughout his career. He has served as the CFO for Arseus Medical, ActoBio Therapeutics, the Akkermansia Company, and most recently with the Kebony Group. He also has extensive prior finance leadership experience with Volvo Cars, serving in roles of increasing responsibility including as CFO for the commercial entity in Europe. Simon Moroney, Chairman of the Board at Biotalys, commented: 'Luc joins us at an important juncture in the company as we continue to advance our innovative product pipeline, and we look forward to his engagement in providing financial guidance on both long-term strategies and day-to-day operations. We are grateful to Douglas for his many contributions to Biotalys, particularly as we streamlined operations and extended our financial runway. We wish him all the best as he pursues new opportunities.' Kevin Helash, CEO of Biotalys, noted: "Luc will be a valuable partner for the management and board as we continue to best position the company for the commercialization of our first products while being prudent stewards of our resources. His extensive experience with other companies in the biotechnology arena is an outstanding fit for Biotalys, and we will leverage his considerable leadership as we execute our long-term global strategy.' Luc Van fraeyenhoven, newly appointed CFO of Biotalys, said: "I am delighted to join the Biotalys team and am eager to be a partner with and resource to the entire organization. Biotalys occupies a unique position in the agricultural and biotech space, and I look forward to contributing to the advancement of this novel, sustainable technology.' Mr. Van fraeyenhoven, a native of Belgium, holds degrees in commercial engineering and transport economics from the University of Antwerp, and a master's in financial management from VLEKHO in Brussels. About Biotalys Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on For further information, please contact: Toon Musschoot, Head of IR & CommunicationT: +32 (0)9 274 54 00E: IR@ Important Notice Biotalys, its business, prospects and financial position remain exposed and subject to risks and uncertainties. A description of and reference to these risks and uncertainties can be found in the annual report on the consolidated annual accounts published on the company's website. This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. Biotalys' actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-05-2025
- Business
- Yahoo
Biotalys and AgroFresh Partner to Protect Fresh Produce
Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food waste Ghent, BELGIUM, and Philadelphia, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Press release Ghent, BELGIUM, and Philadelphia, USA – 20 May 2025, 07.00 CEST – An estimated 14 percent of produce is lost between harvest and retail*, in part due to spoilage from mold and rot. To help address this global challenge, Biotalys (Euronext - BTLS), an agricultural technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, and AgroFresh Solutions, Inc., a global leader in post-harvest solutions for fresh produce, today announced a new collaboration to develop and commercialize sustainable biological fungicides for post-harvest use. Fungicides are already essential to protect fresh produce after harvest, and this collaboration will expand the industry's toolbox with environmentally friendly biological solutions designed to meet the evolving needs of markets around the world. 'Post-harvest freshness solutions are especially critical for high-value and highly perishable crops, where even small losses can result in major food waste and economic impact. As the global leader in post-harvest freshness innovation, AgroFresh is proud to be partnering with Biotalys to develop sustainable biological fungicide solutions,' said Clint Lewis, AgroFresh Chief Executive Officer. 'This collaboration represents an important step forward in expanding our innovation pipeline with novel, sustainable technologies that preserve freshness, reduce waste, and support the success of produce suppliers around the world.' Fungal decay remains one of the most persistent and complex challenges in the post-harvest supply chain. Once harvested, fresh produce loses its natural defenses and becomes highly susceptible to spoilage caused by fungi. These pathogens thrive in common storage and transit environments and can spread rapidly, making consistent and effective disease management essential. As produce moves through increasingly global and quality-driven supply chains, biological tools that can support freshness and reduce loss are becoming more important than ever. 'The global post-harvest fungicide market is valued at $300 million**. Our expansion into this critical segment represents an important step for Biotalys and demonstrates the significant potential and versatility of our protein-based AGROBODY™ platform to help preserve food quality without chemical residues,' said Kevin Helash, Biotalys Chief Executive Officer. 'We are excited about the opportunity to collaborate with the global leader in post-harvest food quality control to bring our biocontrol solutions to this industry segment and make a material difference in this crucial area in the years to come.' Together, AgroFresh and Biotalys are advancing the future of post-harvest protection through science-driven innovation. By combining deep expertise in produce freshness with cutting-edge biocontrol technology, the companies aim to help the fresh produce industry meet today's challenges and adapt to the changing needs of markets worldwide, with sustainable solutions that keep food fresher for longer and reduce global food waste. * Source: FAO report 29 September 2022 – Tackling food loss and waste: a triple win opportunity** Source: 2023 DunhamTrimmer Global Biocontrol Market Report. About AgroFresh Solutions, Inc. AgroFresh is the global leader in post-harvest quality and freshness solutions that enhance quality and extend shelf-life of fresh produce, reducing food loss and waste. AgroFresh has been innovating for more than 40 years to address fresh produce supply chain challenges from all angles with a full suite of integrated storage, packing line and digital solutions. As the pioneer of SmartFreshTM, the world's first introduction to 1-MCP technology used to slow ripening, and UvasysTM, the world's first laminated SO2 generating sheets that prevent fungal decay in produce, AgroFresh empowers growers, packers and retailers to succeed in delivering fresh, quality and sustainable produce from harvest to home. To learn more about AgroFresh, visit About Biotalys Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and food and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has been listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on For further information, please contact: BiotalysToon MusschootHead of IR & CommunicationT: +32 (0)9 274 54 00E: IR@ AgroFreshChristy ToedebuschHead of Global MarketingMobile: (314) 283-5996ctoedebusch@ Important Notice Biotalys, its business, prospects and financial position remain exposed and subject to risks and uncertainties. A description of and reference to these risks and uncertainties can be found in the annual report on the consolidated annual accounts published on the company's website. This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. Biotalys' actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-05-2025
- Business
- Yahoo
Biotalys and AgroFresh Partner to Protect Fresh Produce
Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food waste Ghent, BELGIUM, and Philadelphia, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Press release Ghent, BELGIUM, and Philadelphia, USA – 20 May 2025, 07.00 CEST – An estimated 14 percent of produce is lost between harvest and retail*, in part due to spoilage from mold and rot. To help address this global challenge, Biotalys (Euronext - BTLS), an agricultural technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, and AgroFresh Solutions, Inc., a global leader in post-harvest solutions for fresh produce, today announced a new collaboration to develop and commercialize sustainable biological fungicides for post-harvest use. Fungicides are already essential to protect fresh produce after harvest, and this collaboration will expand the industry's toolbox with environmentally friendly biological solutions designed to meet the evolving needs of markets around the world. 'Post-harvest freshness solutions are especially critical for high-value and highly perishable crops, where even small losses can result in major food waste and economic impact. As the global leader in post-harvest freshness innovation, AgroFresh is proud to be partnering with Biotalys to develop sustainable biological fungicide solutions,' said Clint Lewis, AgroFresh Chief Executive Officer. 'This collaboration represents an important step forward in expanding our innovation pipeline with novel, sustainable technologies that preserve freshness, reduce waste, and support the success of produce suppliers around the world.' Fungal decay remains one of the most persistent and complex challenges in the post-harvest supply chain. Once harvested, fresh produce loses its natural defenses and becomes highly susceptible to spoilage caused by fungi. These pathogens thrive in common storage and transit environments and can spread rapidly, making consistent and effective disease management essential. As produce moves through increasingly global and quality-driven supply chains, biological tools that can support freshness and reduce loss are becoming more important than ever. 'The global post-harvest fungicide market is valued at $300 million**. Our expansion into this critical segment represents an important step for Biotalys and demonstrates the significant potential and versatility of our protein-based AGROBODY™ platform to help preserve food quality without chemical residues,' said Kevin Helash, Biotalys Chief Executive Officer. 'We are excited about the opportunity to collaborate with the global leader in post-harvest food quality control to bring our biocontrol solutions to this industry segment and make a material difference in this crucial area in the years to come.' Together, AgroFresh and Biotalys are advancing the future of post-harvest protection through science-driven innovation. By combining deep expertise in produce freshness with cutting-edge biocontrol technology, the companies aim to help the fresh produce industry meet today's challenges and adapt to the changing needs of markets worldwide, with sustainable solutions that keep food fresher for longer and reduce global food waste. * Source: FAO report 29 September 2022 – Tackling food loss and waste: a triple win opportunity** Source: 2023 DunhamTrimmer Global Biocontrol Market Report. About AgroFresh Solutions, Inc. AgroFresh is the global leader in post-harvest quality and freshness solutions that enhance quality and extend shelf-life of fresh produce, reducing food loss and waste. AgroFresh has been innovating for more than 40 years to address fresh produce supply chain challenges from all angles with a full suite of integrated storage, packing line and digital solutions. As the pioneer of SmartFreshTM, the world's first introduction to 1-MCP technology used to slow ripening, and UvasysTM, the world's first laminated SO2 generating sheets that prevent fungal decay in produce, AgroFresh empowers growers, packers and retailers to succeed in delivering fresh, quality and sustainable produce from harvest to home. To learn more about AgroFresh, visit About Biotalys Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and food and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has been listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on For further information, please contact: BiotalysToon MusschootHead of IR & CommunicationT: +32 (0)9 274 54 00E: IR@ AgroFreshChristy ToedebuschHead of Global MarketingMobile: (314) 283-5996ctoedebusch@ Important Notice Biotalys, its business, prospects and financial position remain exposed and subject to risks and uncertainties. A description of and reference to these risks and uncertainties can be found in the annual report on the consolidated annual accounts published on the company's website. This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. Biotalys' actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.
